UnitedHealth Group Incorporated $UNH Stock Holdings Lifted by RFG Advisory LLC

RFG Advisory LLC raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 442.6% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 28,556 shares of the healthcare conglomerate’s stock after buying an additional 23,293 shares during the period. RFG Advisory LLC’s holdings in UnitedHealth Group were worth $8,909,000 as of its most recent filing with the SEC.

Several other institutional investors also recently modified their holdings of UNH. Bayforest Capital Ltd raised its stake in UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd raised its stake in UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 50 shares during the period. O Brien Wealth Partners LLC raised its stake in UnitedHealth Group by 74.0% during the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock valued at $46,000 after purchasing an additional 37 shares during the period. Kentucky Trust Co raised its stake in UnitedHealth Group by 138.5% during the 1st quarter. Kentucky Trust Co now owns 93 shares of the healthcare conglomerate’s stock valued at $49,000 after purchasing an additional 54 shares during the period. Finally, Nova Wealth Management Inc. raised its stake in UnitedHealth Group by 339.1% during the 1st quarter. Nova Wealth Management Inc. now owns 101 shares of the healthcare conglomerate’s stock valued at $53,000 after purchasing an additional 78 shares during the period. Institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently weighed in on UNH. Sanford C. Bernstein upped their price target on shares of UnitedHealth Group from $379.00 to $433.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 8th. Mizuho upped their price target on shares of UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a research note on Thursday, October 9th. KeyCorp upped their price target on shares of UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 8th. Royal Bank Of Canada dropped their price target on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 30th. Finally, Oppenheimer dropped their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 30th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have given a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $383.09.

UnitedHealth Group Trading Up 1.2%

UnitedHealth Group stock opened at $358.80 on Tuesday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The company has a market capitalization of $324.96 billion, a price-to-earnings ratio of 15.55, a PEG ratio of 2.29 and a beta of 0.47. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The company’s fifty day moving average price is $320.57 and its two-hundred day moving average price is $346.99.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company’s quarterly revenue was up 12.9% compared to the same quarter last year. During the same period in the previous year, the company earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were given a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.